2 results match your criteria: "The First Affiliated Hospital of Soochou University[Affiliation]"
A novel SGLT2 inhibitor, SU-011, improves glycaemic control in rodents without the risk of hypoglycaemia and weight gain.
J Pharm Pharmacol
September 2019
Department of Endocrinology and Metabolism, The First Affiliated Hospital of Soochou University, Suzhou, Jiangsu, China.
Objective: To evaluate the pharmacological characteristics of SU-011, a novel sodium-dependent glucose co-transporter 2 (SGLT2) inhibitor.
Methods: The in vitro activities of SU-011 were investigated in cell-based assays. The urinary glucose excretion, glucose tolerance and the risk of hypoglycaemia were evaluated in mice.
Diagnostic value of circular RNAs as effective biomarkers for cancer: a systematic review and meta-analysis.
Onco Targets Ther
April 2019
Department of Laboratory Medicine, Affiliated Hospital of University of Electronic Science and Technology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, 610072, China.
Increasing evidence has identified circular RNAs (circRNAs) as ideal molecular biomarkers for cancer diagnosis, therapy, and prognosis. However, the overall diagnostic efficiency of circRNAs remains unclear. Thus, this meta-analysis aimed to comprehensively evaluate the diagnostic accuracy of circRNA expression profiles for cancer.
View Article and Find Full Text PDF